Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Dumesny

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Translational Oncology|January 1, 2022
A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabineHong He, Chelsea Dumesny, Ching-Seng Ang, et al.
International Journal of Molecular Sciences|September 13, 2025
P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular NormalisationArian Ansardamavandi, Chelsea Dumesny, Yi Ma, et al.
Cancers|November 13, 2025
The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic CancerArian Ansardamavandi, Chelsea Dumesny, Yi Ma, et al.
Cell Communication and Signaling : CCS|May 26, 2024
Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunityYi Ma, Chelsea Dumesny, Li Dong, et al.
Cancers|December 11, 2025
Evaluation of Nanoparticle-Based Plasma Enrichment on Individuals with Primary and Metastatic Pancreatic CancerChing-Seng Ang, Nicholas A Williamson, Chelsea Dumesny, et al.
American Journal of Translational Research|May 16, 2023
CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stromaNien-Hung Lee, Yi Ma, Ching-Seng Ang, et al.
International Journal of Molecular Sciences|November 9, 2024
A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of GemcitabineHong He, Chelsea Dumesny, Judith A Carrall, et al.
Cancer Letters|December 21, 2019
Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Kai Wang, Yifan Zhan, Nhi Huynh, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Translational Oncology|January 1, 2022
A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabineHong He, Chelsea Dumesny, Ching-Seng Ang, et al.
International Journal of Molecular Sciences|September 13, 2025
P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular NormalisationArian Ansardamavandi, Chelsea Dumesny, Yi Ma, et al.
Cancers|November 13, 2025
The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic CancerArian Ansardamavandi, Chelsea Dumesny, Yi Ma, et al.
Cell Communication and Signaling : CCS|May 26, 2024
Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunityYi Ma, Chelsea Dumesny, Li Dong, et al.
Cancers|December 11, 2025
Evaluation of Nanoparticle-Based Plasma Enrichment on Individuals with Primary and Metastatic Pancreatic CancerChing-Seng Ang, Nicholas A Williamson, Chelsea Dumesny, et al.
American Journal of Translational Research|May 16, 2023
CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stromaNien-Hung Lee, Yi Ma, Ching-Seng Ang, et al.
International Journal of Molecular Sciences|November 9, 2024
A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of GemcitabineHong He, Chelsea Dumesny, Judith A Carrall, et al.
Cancer Letters|December 21, 2019
Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Kai Wang, Yifan Zhan, Nhi Huynh, et al.
Pageof 2